Board Of Trustees

Board of Trustees

The Board of Trustees of the Max Planck Institute for Molecular Genetics supports the Institute and fosters connections between the MPIMG and the public. The members of the Board of Trustees are appointed by the president of the Max Planck Society. They meet regularly at the Institute to stay informed about its work and general development. The Board of Trustees is formed by representatives from the local politics, industry, science, and the media.

Members of the Board of Trustees (appointment period 2014 - 2019)

Prof. Dr. Erwin Böttinger
Vorsitzender des Vorstands
Berlin Institute of Health (BIH), Berlin

Prof. Dr. Andreas E. Busch
Head of Global Drug Discovery
Bayer HealthCare Pharmaceutical, Berlin

Prof. Dr. Karl Max Einhäupl
Chairman of the Executive Board
Charité - Universitätsmedizin Berlin

Prof. Dr. Peter A. Frensch
Vice President for Research
Humboldt-Universität zu Berlin

Prof. Dr. Detlev Ganten
Chairman of the Foundation Board
Charité Foundation, Berlin

Prof. Dr. Monika Schäfer-Korting
Vice President of the
Freie Universität Berlin

Prof. Dr. Karl Sperling
Institute of Human Genetics
Charité - Universitätsmedizin Berlin

Prof. Dr. Günter Stock
President of the
Berlin-Brandenburgischen Academy of Sciences and Humanities, Berlin

Dr. Hartmut Wewetzer
Science editor
Der Tagesspiegel, Berlin

 
loading content